RASPADORI, DONATELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.610
EU - Europa 1.429
AS - Asia 208
AF - Africa 10
OC - Oceania 4
SA - Sud America 3
Totale 3.264
Nazione #
US - Stati Uniti d'America 1.601
GB - Regno Unito 346
IE - Irlanda 345
SE - Svezia 193
IT - Italia 149
RU - Federazione Russa 123
CN - Cina 121
UA - Ucraina 94
FR - Francia 64
DE - Germania 43
SG - Singapore 39
FI - Finlandia 31
TR - Turchia 16
VN - Vietnam 13
CZ - Repubblica Ceca 11
BE - Belgio 10
CA - Canada 7
CI - Costa d'Avorio 5
AU - Australia 4
EG - Egitto 4
IN - India 3
IR - Iran 3
SK - Slovacchia (Repubblica Slovacca) 3
ES - Italia 2
GR - Grecia 2
HK - Hong Kong 2
JP - Giappone 2
KG - Kirghizistan 2
LT - Lituania 2
LU - Lussemburgo 2
MX - Messico 2
NL - Olanda 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
MA - Marocco 1
MK - Macedonia 1
NO - Norvegia 1
PE - Perù 1
PL - Polonia 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 3.264
Città #
Dublin 344
Southend 322
Fairfield 275
Ashburn 156
Chandler 155
Woodbridge 113
Seattle 111
Houston 97
Wilmington 92
Cambridge 80
Ann Arbor 79
Jacksonville 77
Siena 52
Princeton 46
Singapore 31
Beijing 30
Helsinki 24
San Mateo 22
Nanjing 21
San Diego 18
Dearborn 15
Izmir 15
Boardman 14
Dong Ket 12
New York 12
Shanghai 12
Moscow 11
Brno 10
Brussels 10
Menlo Park 10
Florence 9
Rome 9
Shenyang 9
London 8
Nanchang 8
Washington 7
Jinan 6
San Francisco 6
Abidjan 5
Toronto 5
Cairo 4
Changsha 4
Frankfurt am Main 4
Hebei 4
Jiaxing 4
Munich 4
Andover 3
Bratislava 3
Council Bluffs 3
Gussago 3
Los Angeles 3
Milan 3
Ningbo 3
Norwalk 3
Tianjin 3
Atlanta 2
Bishkek 2
Bologna 2
Canberra 2
Chiampo 2
Chiswick 2
Düsseldorf 2
Fremont 2
Guangzhou 2
Haikou 2
Hefei 2
Henderson 2
Hounslow 2
Lancaster 2
Leawood 2
Luxembourg 2
Minamikoshien 2
Málaga 2
Newark 2
Pisa 2
Redwood City 2
Reggio Emilia 2
Salerno 2
San Giuliano Terme 2
Treviso 2
Turin 2
Zanjan 2
Zhengzhou 2
Albignasego 1
Almere Stad 1
Amman 1
Ascoli Piceno 1
Auburn Hills 1
Birmingham 1
Bolzano 1
Borås 1
Castellammare Di Stabia 1
Chongqing 1
Dallas 1
Delhi 1
Des Moines 1
Dubai 1
Falkenstein 1
Forest City 1
Greve in Chianti 1
Totale 2.462
Nome #
Residual peripheral blood CD26+leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission 202
Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia 196
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab 171
Insight into the behavior of hairy cell leukemia by immunogenetic analysis 164
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. 160
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors 158
Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia 150
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients 145
Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia 143
A t(20;21)(q12;q22.3) in a patient with chronic myelocytic leukemia in blastic phase [3] 125
A case of acute myelogenous leukemia: myelodysplastic syndrome with t(2;11)(p21;q23) without MLL rearrangement 122
An unusual presentation of chronic B-cell lymphocytic leukaemia 114
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients 114
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype 113
Selection and Transplantation of Autologous Hematopoietic CD34+ Cells for Patients with Multiple Myeloma 100
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma 94
A BRAF Negative Classic Hairy Cell Leukemia Patient in Long Lasting Complete Remission after Rituximab and Pentostatin 92
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome 84
Fludarabine in patients with advanced and/or resistant B‐chronic lymphocytic leukemia 81
Minimal residual disease in multiple myeloma: State of the art and applications in clinical practice 81
V-H and V-L genes in hairy cell leukemia reveal a dynamic on-going modification of the surface B-cell receptor 78
Anti CD38 monoclonal antibodies for multiple myeloma treatment 78
Trisomy 8 in chronic lymphocytic leukemia: a report of two cases 71
Relationship between immunological response to alpha-IFN treatment in 35 patients with hairy cell leukemia 63
Fludarabine: An active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma 59
Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma 59
Complete resolution of hepatic aspergillosis after non-myeloablative hematopoietic stem cell transplantation in a patient with acute myeloid leukemia 58
Peripheral Blood CD26+ Leukemia Stem Cells Monitoring in Chronic Myeloid Leukemia Patients from Diagnosis to Response to TKIs: Interim Results of a Multicenter Prospective Study (PROSPECTIVE FLOWERS) 51
DART4MM: Daratumumab as Consolidation Therapy in Patients who Already Achieved Optimal Response/MRD Positivity by Next Generation Flow (NGF): Preliminary Results of a Phase 2 Multicenter Study 48
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study 34
Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency 33
Prospective Monitoring of Peripheral Blood CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation 31
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR) 25
Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy 25
“Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow 21
Tp53 disruptions: Is there a marker of poor prognosis in chronic lymphoproliferative disorders? 13
Totale 3.356
Categoria #
all - tutte 13.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020513 0 0 30 90 43 52 55 72 61 61 17 32
2020/2021565 22 37 47 69 33 54 42 80 32 65 39 45
2021/2022387 26 28 30 69 20 16 12 10 15 41 45 75
2022/2023584 33 61 81 74 53 107 14 71 50 13 24 3
2023/2024565 13 11 58 44 21 142 198 6 2 17 8 45
2024/2025213 29 43 141 0 0 0 0 0 0 0 0 0
Totale 3.356